Caprock Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $18.7M | Sell |
51,552
-726
| -1% | -$249K | 0.36% | 46 |
|
|
2026
Q1 | $18.4M | Buy |
52,278
+30,157
| +136% | +$10.8M | 0.45% | 36 |
|
|
2025
Q4 | $7.24M | Buy |
22,121
+720
| +3% | +$228K | 0.15% | 112 |
|
|
2025
Q3 | $6.21M | Buy |
+21,401
| New | +$6.21M | 0.15% | 101 |
|
|
2025
Q1 | $6.15M | Buy |
19,735
+4,465
| +29% | +$1.32M | 0.19% | 90 |
|
|
2024
Q4 | $3.98M | Sell |
15,270
-1,154
| -7% | -$342K | 0.13% | 133 |
|
|
2024
Q3 | $5.29M | Buy |
16,424
+1,017
| +7% | +$333K | 0.19% | 83 |
|
|
2024
Q2 | $4.81M | Buy |
15,407
+6,319
| +70% | +$1.86M | 0.2% | 80 |
|
|
2024
Q1 | $2.58M | Buy |
9,088
+438
| +5% | +$128K | 0.15% | 98 |
|
|
2023
Q4 | $2.49M | Buy |
8,650
+340
| +4% | +$92.6K | 0.16% | 97 |
|
|
2023
Q3 | $2.23M | Buy |
8,310
+1,413
| +20% | +$353K | 0.17% | 89 |
|
|
2023
Q2 | $1.53M | Sell |
6,897
-329
| -5% | -$76.3K | 0.11% | 142 |
|
|
2023
Q1 | $1.75M | Buy |
7,226
+804
| +13% | +$197K | 0.14% | 122 |
|
|
2022
Q4 | $1.69M | Buy |
6,422
+20
| +0.3% | +$5.36K | 0.16% | 101 |
|
|
2022
Q3 | $1.44M | Sell |
6,402
-25
| -0.4% | -$6.06K | 0.14% | 109 |
|
|
2022
Q2 | $1.56M | Sell |
6,427
-130
| -2% | -$31.9K | 0.15% | 103 |
|
|
2022
Q1 | $1.59M | Buy |
6,557
+419
| +7% | +$96.3K | 0.15% | 115 |
|
|
2021
Q4 | $1.38M | Buy |
6,138
+550
| +10% | +$116K | 0.11% | 130 |
|
|
2021
Q3 | $1.19M | Sell |
5,588
-858
| -13% | -$197K | 0.11% | 135 |
|
|
2021
Q2 | $1.57M | Buy |
6,446
+42
| +0.7% | +$10.3K | 0.14% | 109 |
|
|
2021
Q1 | $1.59M | Sell |
6,404
-682
| -10% | -$163K | 0.17% | 93 |
|
|
2020
Q4 | $1.63M | Sell |
7,086
-1,076
| -13% | -$248K | 0.19% | 90 |
|
|
2020
Q3 | $2.07M | Sell |
8,162
-626
| -7% | -$155K | 0.28% | 63 |
|
|
2020
Q2 | $2.07M | Buy |
8,788
+1,995
| +29% | +$455K | 0.31% | 61 |
|
|
2020
Q1 | $1.38M | Buy |
6,793
+232
| +4% | +$50.7K | 0.26% | 76 |
|
|
2019
Q4 | $1.58M | Buy |
6,561
+239
| +4% | +$52.7K | 0.28% | 69 |
|
|
2019
Q3 | $1.22M | Sell |
6,322
-105
| -2% | -$20.2K | 0.24% | 81 |
|
|
2019
Q2 | $1.18M | Sell |
6,427
-778
| -11% | -$139K | 0.23% | 83 |
|
|
2019
Q1 | $1.37M | Buy |
7,205
+860
| +14% | +$164K | 0.27% | 75 |
|
|
2018
Q4 | $1.24M | Buy |
6,345
+194
| +3% | +$37.8K | 0.28% | 71 |
|
|
2018
Q3 | $1.27M | Sell |
6,151
-450
| -7% | -$88.7K | 0.26% | 72 |
|
|
2018
Q2 | $1.22M | Sell |
6,601
-1,664
| -20% | -$294K | 0.26% | 70 |
|
|
2018
Q1 | $1.41M | Buy |
8,265
+32
| +0.4% | +$5.87K | 0.3% | 62 |
|
|
2017
Q4 | $1.52M | Buy |
8,233
+190
| +2% | +$33.6K | 0.3% | 64 |
|
|
2017
Q3 | $1.5M | Buy |
8,043
+547
| +7% | +$96.9K | 0.31% | 62 |
|
|
2017
Q2 | $1.29M | Buy |
7,496
+1,475
| +24% | +$240K | 0.29% | 65 |
|
|
2017
Q1 | $988K | Sell |
6,021
-1,038
| -15% | -$172K | 0.23% | 79 |
|
|
2016
Q4 | $1.03M | Buy |
7,059
+381
| +6% | +$57.3K | 0.26% | 77 |
|
|
2016
Q3 | $1.11M | Buy |
6,678
+1,654
| +33% | +$280K | 0.25% | 95 |
|
|
2016
Q2 | $764K | Sell |
5,024
-94
| -2% | -$14.6K | 0.19% | 129 |
|
|
2016
Q1 | $767K | Buy |
+5,118
| New | +$760K | 0.18% | 120 |
|
Other funds holding AMGN
FFM
SP
Caprock Group's AMGN Position: Q2 2026 in Review
Caprock Group reduced its Amgen (AMGN) stake by 1.4% in Q2 2026, selling an estimated $249K and leaving 51,552 shares worth $18.7M. The position accounts for 0.36% of the portfolio, ranked #46.
Caprock Group first reported a position in AMGN in Q1 2016 and has held it in 41 quarters since. 1,202 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Caprock Group held 51,552 shares of Amgen worth $18.7M as of Q2 2026.
- Caprock Group sold 726 Amgen shares in Q2 2026, an estimated $249K.
- Amgen made up 0.36% of Caprock Group's portfolio in Q2 2026, its #46 holding.
- Caprock Group first reported a position in Amgen in Q1 2016 and has held it in 41 quarters since.
- 1,202 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Caprock Group's 13F filing for Q2 2026, filed 27 Jul 2026.